These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24875728)

  • 1. Is there a relationship between executive functions and academic success in children with neurofibromatosis type 1?
    Gilboa Y; Rosenblum S; Fattal-Valevski A; Toledano-Alhadef H; Josman N
    Neuropsychol Rehabil; 2014; 24(6):918-35. PubMed ID: 24875728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecological approach of executive functions using the Behavioural Assessment of the Dysexecutive Syndrome for Children (BADS-C): Developmental and validity study.
    Roy A; Allain P; Roulin JL; Fournet N; Le Gall D
    J Clin Exp Neuropsychol; 2015; 37(9):956-71. PubMed ID: 26332175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Key Search Subtest of the Behavioural Assessment of the Dysexecutive Syndrome in Children (BADS-C) Instrument Reveals Impaired Planning Without External Constraints in Children With Neurofibromatosis Type 1.
    Riva D; Vago C; Erbetta A; Saletti V; Esposito S; Micheli R; Bulgheroni S
    J Child Neurol; 2017 Mar; 32(4):387-396. PubMed ID: 28193119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does attention-deficit-hyperactivity disorder exacerbate executive dysfunction in children with neurofibromatosis type 1?
    Payne JM; Arnold SS; Pride NA; North KN
    Dev Med Child Neurol; 2012 Oct; 54(10):898-904. PubMed ID: 22845611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior.
    Payne JM; Hyman SL; Shores EA; North KN
    Child Neuropsychol; 2011; 17(4):313-29. PubMed ID: 21347908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent and Teacher Perspectives on Emerging Executive Functioning in Preschoolers With Neurofibromatosis Type 1: Comparison to Unaffected Children and Lab-Based Measures.
    Casnar CL; Klein-Tasman BP
    J Pediatr Psychol; 2017 Mar; 42(2):198-207. PubMed ID: 27189686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The self-concept of children and adolescents with neurofibromatosis type 1.
    Barton B; North K
    Child Care Health Dev; 2007 Jul; 33(4):401-8. PubMed ID: 17584395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas.
    Hou Y; Wu X; Allen T; Toledo-Tamula MA; Martin S; Gillespie A; Goodwin A; Widemann BC; Wolters PL
    J Int Neuropsychol Soc; 2023 Nov; 29(9):839-849. PubMed ID: 36750981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children.
    Descheemaeker MJ; Ghesquière P; Symons H; Fryns JP; Legius E
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):33-46. PubMed ID: 15634310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive features that distinguish preschool-age children with neurofibromatosis type 1 from their peers: a matched case-control study.
    Lorenzo J; Barton B; Arnold SS; North KN
    J Pediatr; 2013 Nov; 163(5):1479-83.e1. PubMed ID: 23910685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioural assessment of the Dysexecutive Syndrome for Children (BADS-C): an examination of construct validity.
    Engel-Yeger B; Josman N; Rosenblum S
    Neuropsychol Rehabil; 2009 Oct; 19(5):662-76. PubMed ID: 19169936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of ADHD on the cognitive and academic functioning of children with NF1.
    Pride NA; Payne JM; North KN
    Dev Neuropsychol; 2012; 37(7):590-600. PubMed ID: 23066937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive functions in preschool-aged children with neurofibromatosis type 1: Value for early assessment.
    Beaussart-Corbat ML; Barbarot S; Farges D; Martin L; Roy A
    J Clin Exp Neuropsychol; 2021 Mar; 43(2):163-175. PubMed ID: 33685350
    [No Abstract]   [Full Text] [Related]  

  • 16. Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors.
    Krivitzky LS; Walsh KS; Fisher EL; Berl MM
    Child Neuropsychol; 2016; 22(7):870-88. PubMed ID: 26143938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Praxis skills and executive function in children with neurofibromatosis type 1.
    Remigereau C; Roy A; Costini O; Barbarot S; Bru M; Le Gall D
    Appl Neuropsychol Child; 2018; 7(3):224-234. PubMed ID: 28296469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Executive dysfunction in children with neurofibromatosis type 1: a study of action planning.
    Roy A; Roulin JL; Charbonnier V; Allain P; Fasotti L; Barbarot S; Stalder JF; Terrien A; Le Gall D
    J Int Neuropsychol Soc; 2010 Nov; 16(6):1056-63. PubMed ID: 20682087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
    Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
    Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanisms of writing difficulties among children with neurofibromatosis type 1.
    Gilboa Y; Josman N; Fattal-Valevski A; Toledano-Alhadef H; Rosenblum S
    Res Dev Disabil; 2014 Jun; 35(6):1310-6. PubMed ID: 24691356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.